BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 1904188)

  • 1. Etidronate for hypercalcemia of malignancy and osteoporosis.
    Horowitz E; Miller JL; Rose LI
    Am Fam Physician; 1991 Jun; 43(6):2155-9. PubMed ID: 1904188
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intravenous disodium etidronate therapy in Paget's disease of bone and hypercalcemia of malignancy. Effects on biochemical parameters and bone histomorphometry.
    Meunier PJ; Chapuy MC; Delmas P; Charhon S; Edouard C; Arlot M
    Am J Med; 1987 Feb; 82(2A):71-8. PubMed ID: 3103438
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bisphosphonates in the treatment of disorders of mineral metabolism.
    Singer FR; Minoofar PN
    Adv Endocrinol Metab; 1995; 6():259-88. PubMed ID: 7671099
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Etidronic acid. A review of its pharmacological properties and therapeutic efficacy in resorptive bone disease.
    Dunn CJ; Fitton A; Sorkin EM
    Drugs Aging; 1994 Dec; 5(6):446-74. PubMed ID: 7858370
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Critical drug appraisal: etidronate intermittent cyclic therapy for postmenopausal osteoporosis.
    Miller PD
    Br J Clin Pract; 1996; 50(1):23-31. PubMed ID: 8729598
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of intravenous etidronate disodium on skeletal and calcium metabolism.
    Kanis JA; Urwin GH; Gray RE; Beneton MN; McCloskey EV; Hamdy NA; Murray SA
    Am J Med; 1987 Feb; 82(2A):55-70. PubMed ID: 3103437
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of oral administration of etidronate disodium in maintaining normal serum calcium levels in previously hypercalcemic cancer patients.
    Ringenberg QS; Ritch PS
    Clin Ther; 1987; 9(3):318-25. PubMed ID: 3111705
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Development of bisphosphonates].
    Nakatsuka K
    Nihon Rinsho; 2003 Feb; 61(2):219-25. PubMed ID: 12638211
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Etidronate disodium for Paget's disease.
    Med Lett Drugs Ther; 1978 Sep; 20(18):78-9. PubMed ID: 99647
    [No Abstract]   [Full Text] [Related]  

  • 10. Review of fracture experience during treatment of Paget's disease of bone with etidronate disodium (EHDP).
    Johnston CC; Altman RD; Canfield RE; Finerman GA; Taulbee JD; Ebert ML
    Clin Orthop Relat Res; 1983; (172):186-94. PubMed ID: 6401608
    [No Abstract]   [Full Text] [Related]  

  • 11. Etidronate disodium: a new therapy for hypercalcemia of malignancy. Proceedings of a symposium.
    Am J Med; 1987 Feb; 82(2A):1-78. PubMed ID: 3103434
    [No Abstract]   [Full Text] [Related]  

  • 12. Etidronate-an oral treatment for Paget's disease of bone.
    Drug Ther Bull; 1982 Apr; 20(7):25-6. PubMed ID: 6804199
    [No Abstract]   [Full Text] [Related]  

  • 13. [Treatment of osteoporosis with etidronate].
    Takada J; Iba K; Yamashita T; Ishii S
    Nihon Rinsho; 2004 Feb; 62 Suppl 2():410-4. PubMed ID: 15035161
    [No Abstract]   [Full Text] [Related]  

  • 14. History of etidronate.
    Watts NB; Chesnut CH; Genant HK; Harris ST; Jackson RD; Licata AA; Miller PD; Mysiw WJ; Richmond B; Valent D
    Bone; 2020 May; 134():115222. PubMed ID: 31911206
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Osteolysis, then fracture of the femur in a Paget's disease patient treated with high-dose disodium etidronate].
    Pinel B; Cambon C; Thomine JM; Cauvin M; Daragon A; Deshayes P
    Rev Rhum Mal Osteoartic; 1984; 51(7-8):417-8. PubMed ID: 6436959
    [No Abstract]   [Full Text] [Related]  

  • 16. Experience with sodium etidronate in the treatment of symptomatic Paget's disease of bone.
    Bourke J; Murphy M; Fennelly JJ
    Ir Med J; 1985 Oct; 78(10):300. PubMed ID: 3934108
    [No Abstract]   [Full Text] [Related]  

  • 17. [Treatment of Paget's disease with the combined administration of calcitonin and disodium etidronate].
    Ghiringhelli G; Fogel M; Varela de Rodríguez J; Casco C; Mautelén C; Nusimovich B
    Medicina (B Aires); 1982; 42(1):16-20. PubMed ID: 6813634
    [No Abstract]   [Full Text] [Related]  

  • 18. Intravenous etidronate in the management of malignant hypercalcemia.
    Ryzen E; Martodam RR; Troxell M; Benson A; Paterson A; Shepard K; Hicks R
    Arch Intern Med; 1985 Mar; 145(3):449-52. PubMed ID: 3919667
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapies for symptomatic primary osteoporosis.
    Licata AA
    Geriatrics; 1991 Nov; 46(11):62-3, 66-7. PubMed ID: 1937062
    [TBL] [Abstract][Full Text] [Related]  

  • 20. From bathtub ring to osteoporosis: a clinical review of the bisphosphonates.
    Licata AA
    Cleve Clin J Med; 1993; 60(4):284-90. PubMed ID: 8339454
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.